v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:                
Net income $ 6,713 $ 30,232   $ 17,517 $ (12,343) $ 36,945 $ 5,174  
Adjustments to reconcile net income to net cash provided by operating activities:                
Depreciation and amortization 69,500     45,400   116,407 90,327  
Equity compensation expense           8,159 908  
Amortization of debt issuance costs 2,300     5,600   4,946 11,071  
Non-cash lease expense           1,648 1,786  
Provision for credit losses           4,589 2 $ 7,101
Inventory reserve           476 250  
Gain on sale of property, plant and equipment (1,173)     (738)   (1,173) (721)  
Change in fair value of derivatives           (14,293) 21,529  
Deferred tax provision           7,104 761  
Changes in operating assets and liabilities, exclusive of effects of business acquisition:                
Accounts receivable           (45,933) (21,705)  
Inventories           (3,147) (4,907)  
Contract assets           12,000 (958)  
Prepaid expenses and other current assets           4,671 (10,681)  
Accounts payable           21,983 10,954  
Accrued and other liabilities           11,871 (14,971)  
Contract liabilities           6,308 29,149  
Other assets           63 0  
Net cash provided by operating activities           172,624 117,968  
Cash flows from investing activities:                
Net cash acquired in acquisition of CSI Compressco LP           9,458 0  
Purchase of property, plant and equipment           (177,186) (94,034)  
Proceeds from sale of property, plant and equipment           411 1,055  
Other           (35) (14)  
Net cash used in investing activities           (167,352) (92,993)  
Cash flows from financing activities:                
Borrowings on debt instruments           1,945,775 499,279  
Payments on debt instruments           (1,867,851) (428,812)  
Principal payments on other borrowings           (1,843) 0  
Payment of debt issuance cost           (16,346) (32,202)  
Dividends paid to stockholders (32,578) (29,815) $ (29,793)     (62,393) 0  
Principal payments on finance leases           (408) 0  
Offering costs           (1,162) 0  
Cash paid for shares withheld to cover taxes           (294) 0  
Distribution to stockholders           0 (42,300)  
Distribution to noncontrolling interest           (2,460) 0  
Net cash used in financing activities           (6,982) (4,035)  
Net (decrease) increase in cash and cash equivalents           (1,710) 20,940  
Cash and cash equivalents - beginning of period   $ 5,562     $ 20,431 5,562 20,431 20,431
Cash and cash equivalents - end of period $ 3,852   $ 5,562 $ 41,371   3,852 41,371 $ 5,562
Supplemental cash disclosures:                
Cash paid for interest           40,861 116,370  
Cash paid for taxes           9,225 5,726  
Supplemental disclosure of non-cash investing activities:                
Decrease in accrued capital expenditures           2,702 9,946  
Supplemental disclosure of non-cash financing activities:                
Dividends equivalent           (455) 0  
Issuance of common shares           188,099 0  
Issuance of preferred shares and noncontrolling interest           $ 154,186 $ 0  

Source

HTML PDF
ZIP